SlideShare a Scribd company logo
Combined Oral 
Contraceptives 
Dr Shashwat K. Jani. 
M.S. ( Gynec ) 
Diploma in Endoscopy. 
Assistant Professor, Smt. N.H.L. Medical College. 
Sheth V. S. General Hospital, Ahmedabad. 
( M ) : 99099 44160. 
E- mail : drshashwatjani@gmail.com
Introduction 
 World’s population expected to reach 9 billion by 2050. 
 India accounts for 18% of World’s population… !!! 
 Annually, 529,000 maternal deaths & 50 million 
morbidity. 
 In India, contraceptive prevalence is 48.3% . 
 21% of all pregnancies resulting live births are 
unplanned….!!! 
 If unmet need for contraception was met, we can avoid 
52 million unwanted pregnancies 
25-50% of maternal deaths 
( Hindin MJ, Lancet. 2007;370:1297-8 ) 
Dr Shashwat Jani. 9909944160 2
Dr Shashwat Jani. 9909944160 3
Dr Shashwat Jani. 9909944160 4
 1st Clinical trials of COC were 
described by John Charles Rock & 
Goodwin Pincus with approval of 
marketing in USA in 1960. 
Within 5 years it was used by 30 
millions women all over the world. 
At the moment , COC is used by over 
100 million women worldwide. 
Dr Shashwat Jani. 9909944160 5
Combined Oral Contraceptives ( COC ) 
 Commonly known as the “ Pill “ 
Widely Accepted & Most Effective 
Reversible method of Fertility Control. 
 In 1951, India was the 1st country in 
world to introduce COC in National 
programme of Family Planning. 
Dr Shashwat Jani. 9909944160 6
COC : Estrogen + Progestogen 
 Estrogen : 
2 types : - Ethinyl Estradiol ( EE ) 
- Mestranol ( Not used ) 
Dr Shashwat Jani. 9909944160 7
PROGESTOGENS : 
( 4 Groups ) 
1 ) Norethisterone Group : ( 1st generation Pills ) 
Moderate Androgenic property …. 
Norethisterone, 
Norethisterone Acetate , 
Ethiynoidal diacetate , 
Lynestrenol 
2 ) Norgestrel : ( 2nd generation pills ) 
Strong Progestogenic & Androgenic property…. 
Dr Shashwat Jani. 9909944160 8
3 ) 19 – nor testosterone derivatives : 
( 3rd generation pills ) 
Anti ovulatory function by suppressing Gonadotropin… 
Desogestrel, 
Gestodene, 
Norgestimate. 
4 ) Spironolactone analogue : 
Antiandrogenic & Anti mineralocorticoid … 
Drosperinone ( DRSP ) 
Dr Shashwat Jani. 9909944160 9
A comparison of various progestins… 
Progestin Estro-genic 
Anti-estrogenic 
Andro-genic 
Antiandro 
-genic 
Antimineralo 
-corticoid 
Progesterone - - - + + 
Older progestins: 
MPA 
- 
- 
+ 
- 
- 
Norethisterone 
- 
+ 
+ 
- 
- 
Levonorgestrel 
- 
+ 
+ 
- 
- 
Newer progestins: 
Desogestrel 
Cyproterone 
acetate 
- 
- 
- 
- 
- 
- 
- 
+ 
- 
- 
Drospirenone - - - + +
Types of COC 
Dr Shashwat Jani. 9909944160 11
1) Monophasic 
 Contains Estrogen & Progesterone in same 
amount in Each pill . 
 Divided in 2 subgroups : 
- Low dose pills : EE 30 – 35 microgm 
- Very low dose pills : EE 15 – 25 microgm. 
Mala - N 
• dl – NGL 0.15 mg 
• EE 0.03 mg 
Mala - D 
• l – NGL 0.15 mg 
• EE 0.03 mg 
Dr Shashwat Jani. 9909944160 12
2 ) Multiphasic 
 Contains low or variable amounts of E and P in 2 
( biphasic ) or 3 ( triphasic ) phases of cycles. 
 Biphasic : constant EE – 35 microgm 
progestogens : low in first 10 days 
higher in next 11 days . 
NOT POPULAR – MORE FAILURE RATE . 
 
NOT AVAILABLE IN INDIA … 
Dr Shashwat Jani. 9909944160 13
 Triphasic : 
Triquilar – 
- 0.03 EE +0.5mg l-norgestrel (1 - 6) 
- 0.03 EE +0.75mg l-norgestrel (7-11) 
- 0.03 EE +0.125mg l-norgestrel (12 - 21) 
Total monthly intake – 0.68mg EE +1.92mg progesterone 
• Adv. – high efficacy rates 
- few side effects 
- less break through bleeding 
- does not affect s.cholesterol & LIPIDS 
• Disadv. – high pregnancy rates if errors in pill intake . 
Dr Shashwat Jani. 9909944160 14
Mechanism of action: 
1 ) Inhibition of Ovulation : 
 both hormones act on Hypothalamo pituitary 
axis , suppress release of FSH & LH from Ant. 
Pituitary. 
E – inhibits FSH. 
P – inhibits preovulatory LH Surge , less effect 
on FSH. 
Dr Shashwat Jani. 9909944160 15
2 ) Endometrial Hyperplasia : 
 stromal oedema , decidual reaction & 
regression of glands making endometrium 
nonreceptive to embryo. 
3 ) Cervical mucus : 
thick , viscid , scanty . 
impaired sperm transport & penetration. 
4 ) May affect tubal motility & alter tubal 
transport. 
Dr Shashwat Jani. 9909944160 16
Selection of the patient 
 Detail history ( headache , migraine , etc…) 
 Thorough general examination 
( Breast , blood pressure… ) 
 Pelvic examination to exclude cervical 
pathology. 
 Cervical cytology 
 Rule out any other contraindications. 
Dr Shashwat Jani. 9909944160 17
Checklist for Prescribing COC… 
Last menstrual period, rule out pregnancy 
Less than 6 months postpartum & lactating? 
Age, Cigarette smoking, h/o migraine 
Known case of diabetes or hypertension 
History of stroke, MI or thrombosis 
h/o jaundice/ liver disease 
h/o breast/ genital tract malignancies 
h/o drug intake: Antitubercular, antiepileptic 
Dr Shashwat Jani. 9909944160 18
Administration 
New User : 
- 1st day of Cycle . 
- Daily 1 tab. Preferably at night for consecutive 21 days. 
- Continued for 21 days and then 7 days break ( with 
iron tablets ) . 
- Next pack of Pill should be started on 8th day , 
IRRESPECTIVE OF BLEEDING ( same day of the week , pill 
finished ). 
- Simple Regimen of “ 3 WEEKS ON & 1 WEEK OFF “ 
- No break between packs. 
 Can start pill up to 5 days of bleeding with extra 
precaution with condom for next 7 days. 
Dr Shashwat Jani. 9909944160 19
Missed Tablets : 
1 missed – Take 2 tablets next day . 
2 or 3 missed – Take 2 tablets on two consecutive 
days and continue the rest of the pack. 
+Another Contraceptive for 1 week. 
Dr Shashwat Jani. 9909944160 20
• Lactating Women – Progestogen only pills / 
Combined pills after 6 months 
• Non Lactating Women – Combined oral pills 
after 3 to 6 weeks or after menstruation 
• 1st / 2nd Trimester abortion – during first 7 
days. 
• Amenorrhea : At any time after excluding 
pregnancy + barrier method for 7 days. 
Dr Shashwat Jani. 9909944160 21
Extended Use of COC… 
(Seasonale) 
Available since 2003 
150μg of LNG + 30μg of EE 
Only Active Pills taken continuously for 84 days, 
then break for 7 days. 
Fewer periods (4 in a year) 
Pearl index- 0.78 
Breakthrough bleeding/ spotting – First few 
cycles
Follow up … 
 Examined after 3 months , then after 
6 months and then yearly . 
 Ask for any symptoms… 
 Examination for breast , pelvis, BP & weight & 
cervical cytology. 
Dr Shashwat Jani. 9909944160 23
Effectiveness… 
Failure rate : 0.1% 
Failure rate are mainly 
due to missed pills. 
Dr Shashwat Jani. 9909944160 24
How long can be continued …??? 
In properly selected patient without 
any risk factor , benefits are more , 
and so can be continued up to age of 
50 with careful monitoring. Offers 
dual advantage of Contraception and 
HRT. 
For spacing of birth : 3 – 5 years. 
Dr Shashwat Jani. 9909944160 25
Advantages… 
• Prevention of pregnancy 
India - MMR 1per 57 i.e. 400 in 1,00,000 
2/5th of these deaths can be prevented by use 
of OCs 
• Cyclical Stabilisation 
Great social advantage. 
Withdrawl bleeding is predictable & 
postponed safely by taking more low dose pills 
contineously . 
Dr Shashwat Jani. 9909944160 26
• Cure of Menstrual Disorders 
Dysmenorrhoea & Ovulation pain – By inhibiting 
ovulation & production of PG . 
Menorrhagia & Metrorrhagia - Norgestrel High dose oral 
pills more useful. 
Lessens PMT. 
• Protection against Cancer 
a) Endometrial cancer- Reduction by 50 % 
effect persists for 15 yrs. 
b) Ovarian Cancer – Reduction by 40 % 
effect persists for 10 yrs. 
c) Choriocarcinoma – Indirectly prevention by preventing 
pregnancy. 
Dr Shashwat Jani. 9909944160 27
• Protection against benign tumors 
1) Fibrocystic and Fibroadenomatous disease 
2) Ovarion Functional Cysts 
1) Follicular Cyst – 50 % 
2) Corpus Luteum Cyst – 80 % 
3) Fibroid Uterus - Reduction by 30% 
Low Dose OC’s reduce fibroid ( WHO 1996) 
Dr Shashwat Jani. 9909944160 28
• Protection against diseases 
1) Ectopic Pregnancy 
2) PID 
3) Anaemia and Malnutrition 
4) Endometriosis 
5) Acne and Hirsutism 
6) DUB 
7) Osteoporosis 
• Simplicity and Attractiveness 
• No Affection on Future fertility ( 3 months ) 
Dr Shashwat Jani. 9909944160 29
Emergency Contraception… 
1) Yuzpe regimen – 
0.1mg EE + 1 mg dl-Norgestrel 
1st dose Within 72 Hrs of Contact 
Repeated after 12 Hrs. 
2) Ovral 
1st dose 2 tablets within 72 hrs. 
2nd dose 2 tablets after 12 hrs. 
3) Overal – L 
1ST dose 4 tablets within 72 hrs. 
2nd dose 4 tablets after 12 hrs. 
Dr Shashwat Jani. 9909944160 30
Minor Side Effects… 
• Nausea, Vomiting and Lack of appetite 
• Break through bleeding 
• Menorrhagia and irregular bleeding 
• Oligomenorrhoea and Amenorrhoea 
• Breast changes – Heaviness and Tenderness 
• Vaginal Discharge – Cx -erosion, dysplasia causes 
leucorrhoea 
• Headache and Migraine 
• Chloasma 
• Wt. Gain 
• Psychosexual Trouble – Depression, Loss of Libido 
• Others - Leg Cramps, Dimness of Vision 
Dr Shashwat Jani. 9909944160 31
Major Side Effects… 
• Cardiovascular Diseases 
1) MI – Increased Risk in heavy smokers 
2) Ischaemic Stroke - 1.5 times more 
3) Haemorrhagic Stroke – double risk 
4) Venous Thromboembolism – Risk increases 
with age, recent surgery and thrombophilia 
• Hypertension - In women more than 35 Yrs. 
• Carcinogenecity 
1) Breast Cancer 
2) Cervical Cancer 
Dr Shashwat Jani. 9909944160 32
Interaction With Drugs… 
1) Barbiturates , Sulphonamides, Rifampicin 
and Anticonvulsant interfere with OC’s and 
failure rate increases 
2) Interaction with antidiabetic drugs 
3) Vit. C aggravates the effect of COC. 
Dr Shashwat Jani. 9909944160 33
Absolute Contraindications… 
(WHO Category IV) 
• Migraine, with focal Neurological Symptoms 
• Pregnancy and breast feeding ( 6 Months) 
• Severe Hypertension 
• Complicated valvular heart disease 
• D.M. with vascular complications 
• Active hepatitis, liver tumors 
• Major Surgery 
• Prolonged Immobilization . 
Dr Shashwat Jani. 9909944160 34
Indications of Withdrawal : 
 Severe migraine 
Visual or speech disturbances 
Sudden chest pain 
Unexplained fainting attack or acute vertigo 
Severe leg cramps 
Excessive weight gain 
Severe depression 
Prior to surgery ( Atleast 6 weeks ) 
Patient wants pregnancy …  
Dr Shashwat Jani. 9909944160 35
NEWER 
CONTRACEPTIVES 
Dr Shashwat Jani. 9909944160 36
MALE 
 GOSSYPOL : 
- A Chinese drug … !!! 
 
- extract from Cotton seed. 
- Oral 10 – 20 mg daily for 3 months then 20 mg 
twice weekly. 
- Inhibit Spermatogenesis by acting on 
seminiferous tubules. 
- S/E : fatigue, decrease libido, hypokalamic 
paralysis. 
Dr Shashwat Jani. 9909944160 37
Polyurethane Male Condom 
• Stronger and thinner than 
latex condoms 
• Better heat transmission 
• Can safely be used with oil-based 
lubricants 
• Can be used by those with 
latex allergies
 GnRH Analogues : 
- decline in sperm density , sperm motility, 
decrease in testosterone level. 
- Marked loss of libido makes it unacceptable . 
Add back therapy with Testosterone is given. 
Dr Shashwat Jani. 9909944160 39
Male Hormonal Contraception 
• Recent trials at Andrology Clinic, 
Concord Hospital 
• Depo Provera plus testosterone 
implants 3 monthly. 
• Very low sperm count (less than 1 
million per ml) in all men on trial - 
80% had no sperm. 
• Few side-effects 
• Similar regime using an oral 
progestogen and testosterone 
implants being trialed in UK 
• Implants and testosterone also 
being trialled.
RISUG : 
- “Reversible Inhibition of Sperm Under 
Guidence . “ 
- Developed by IIT & AIIMS. 
- clear polymer gel made of Styrene maleic 
anhydrate ( SMA ) mixed with Dimethyl 
Sulphoxide ( DMSO ) injected in to Vas 
deferens  partially blocks Vas , preventing 
sperm from coming in to ejaculate. 
- Phase I & Phase II trials cleared. 
- VASALGEL is similar to it. 
Dr Shashwat Jani. 9909944160 41
Intra Vas Device ( IVD ) – Shug : 
- 2 devices inserted in to each Vas . 
- Needs special surgical skill. 
- wider trials needed. 
Dr Shashwat Jani. 9909944160 42
Voegeli’s Heat Method 
• A small increase in the temperature of the testes has a 
large negative impact on the production of sperm 
(spermatogenesis). 
• Voegeli’s program for temporary sterilization is as 
follows: 
“A man sits in a [shallow or testes-only] bath of 116 
degrees Fahrenheit for forty-five minutes daily for 
three weeks. 
Six months of sterility results, after which normal 
fertility returns. 
For longer sterility, the treatment is repeated. ” 
• . 
Dr Shashwat Jani. 9909944160 43
Artificial Cryptorchidism/ Suspensories 
(a) testes in normal position; 
(b) testes raised to near inguinal canal; testes held in 
place with 
(c) briefs with ring of soft rubber or (d) ring alone. 
Dr Shashwat Jani. 9909944160 44
Gendarussa 
• First nonhormonal male contraceptive pills. 
• Developed by Indonesia. 
• Active ingredient in Gendarussa disrupts an 
enzyme in the sperm head, which weakens 
the ability of the sperm to penetrate the 
ovum. 
• The effect is short term and reversible – 
having no effect on male hormones. 
• Still under clinical trials… 
Dr Shashwat Jani. 9909944160 45
Nifedipine – CCB 
• CCBs also partially block the calcium channels 
within the cell membranes of sperm. This 
affects sperm function rather than production. 
• A man taking nifedipine produces a normal 
amount of sperm, and the sperm appear 
functional when viewed through a 
microscope. But in vitro tests show that these 
sperm cannot fertilize an egg. 
Dr Shashwat Jani. 9909944160 46
Male Vaccines … 
• Scientists are trying to isolate, identify, and 
produce Anti sperm surface antigens which 
will hinder sperm – egg without side effects. 
• Will take long time… 
Dr Shashwat Jani. 9909944160 47
Other Ongoing trials… 
• Use of following as Male Contraceptives… 
1 ) Neem extracts. 
2 ) retinoic receptor antagonist 
3 ) papaiya seed extracts 
4 ) olealonic acid 
Dr Shashwat Jani. 9909944160 48
FEMALE 
Many researches are going 
on for development of newer 
Contraceptives for females which are 
either Non Hormonal OR having low 
dose of Estrogen and newer 
Progestogens. 
Dr Shashwat Jani. 9909944160 49
PATH Women’s Condom 
• Polyurethane condom 
pouch 
• Foam dots improve 
adherence to vaginal 
walls 
• Soft outer ring 
• Dissolving capsule 
Dr Shashwat Jani. 9909944160 50
SILCS Diaphragm 
• Cervical barrier device 
• One-size-fits most 
• Developed with input 
from women and 
men in multiple 
countries 
• Regulatory application 
in Europe & US. 
Dr Shashwat Jani. 9909944160 51
Centchroman ( Saheli ) 
• Ormeloxifene . 
• research product of CDRI , Lucknow 
• Non steroidal , potent anti estrogenic , weak 
estrogenic. 
• Prevent implantation of fertilized ovum . 
• Orally 30 mg twice weekly for first 3 months 
then once a week. 
• Avoided in PCOD, liver , kidney disease. 
Dr Shashwat Jani. 9909944160 52
Non contraceptive uses … 
• DUB 
• Endometrial Hyperplasia 
• Endometriosis 
• Breast cancer 
• HRT 
Dr Shashwat Jani. 9909944160 53
Combined Injectable 
Contraceptives 
• CYCLOFEM : 
- DMPA 25 mg + Ostradiol cypionate 5 mg. 
• MESIGYNA : 
- NET- EN 50 mg + Oestradiol valerate 5 mg. 
• Given within first 5 days of menstruation 
• Next dose on same date of each month. 
Dr Shashwat Jani. 9909944160 54
New formulation of Depo-Provera: 
Depo-subQ Provera 104, for delivery with Uniject 
Depo-subQ Provera 104: 
 New formulation for subQ injection 
 30% lower dose (104 mg vs. 150 mg) 
 Rapid onset of action 
 Same effectiveness, same length of protection (>3 months) 
 Approved by USFDA (2005) and UK 
 Potential for home- and self-injection 
 Available for roll-out in 2011; Acceptability studies to begin in 
mid-2010 
Uniject: 
 Single dose, single package 
 Prefilled, sterile, non-reusable 
 Short needles for subQ injection (easier use by non-clinical 
personnel/CHWs) 
 Compact; easy to use and store 
Potential “home 
run”
Transdermal delivery system 
• Nestorone ( newer progestin ) : 
- Available as Cream & Patch. 
- Patches used like pills : 3 weeks ON 1 week OFF. 
Dr Shashwat Jani. 9909944160 56
VAGINAL RINGS 
• LNG ring covered by silastic tube . 
• Delivers 20 microgm / day 
• Replaced every 3 months. 
Dr Shashwat Jani. 9909944160 57
Combined Ring – NUVA RING : 
• Soft, transperent, ethinyl 
vinyl ring 
• Releases EE 15 microgm 
+ Etonogestrel daily over 
a period of 21 days. 
• Then removed , after 1 
week ( bleeding ) new 
ring inserted. 
• S/E : headache, 
leucorrhea, vaginitis 
Dr Shashwat Jani. 9909944160 58
LNG ROD 
• Implant with total 150 mg of LNG 
( 75 mg / rod ) is found effective for 5 years. 
UNIPLANT 
• Single rod implant 
• Nomegestrol 38 mg. 
• Releases 100 microgm / day. 
• For 1 year. 
Dr Shashwat Jani. 9909944160 59
Biodegradable 
• Cipronor ( Single Capsule) – IMPLANTS : 
- LNG 26 mg 
- begins to disappear after 12 months. 
• INJECTABLE : 
- Microsphere of 0.06 – 0.1 mm diameter with 
Norethindrone with or without EE. 
- Given over Gluteal muscle. 
- Once injected , can’t be removed. 
Dr Shashwat Jani. 9909944160 60
Quinacrine pellet 
• It acts as Sclerosing agent 
• Inserted transcervically through hysteroscope 
in proliferative phase. 
• Repeated in next cycle. 
• Long term results are awaited. 
Dr Shashwat Jani. 9909944160 61
Frameless IUD - Gynefix 
• Made of 6 copper beads ( 330 sqmm of Cu ) 
on monofilament polypropylene thread. 
• Thread is knotted at one end , embeded in to 
fundal myometrium up to 1 cm. 
• Reduced risk of Expulsion, Dysmenorrhoea, 
Bleeding , Infection. 
• Can be used in Nulliparous. 
• Removed with Hook. 
Dr Shashwat Jani. 9909944160 62
Gynefix 
Dr Shashwat Jani. 9909944160 63
ESSURE 
• Transcervical 
sterilisation 
• 4 cm long , 2 mm 
diameter microcoil 
• Spring like device 
• Inserted in each 
fallopian tube through 
hysteroscope. 
• Tube is blocked 
permanently when scar 
tissue grow inside. 
Dr Shashwat Jani. 9909944160 64
Dr Shashwat Jani. 9909944160 65

More Related Content

What's hot

Dysmenorrhea
DysmenorrheaDysmenorrhea
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
Rashna Sharmin
 
Dilatation and curettage
Dilatation and curettageDilatation and curettage
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
Pradeep Garg
 
Abruptio placentae
Abruptio placentae Abruptio placentae
Abruptio placentae
Shailendra Veerarajapura
 
Female infertility and its management
Female infertility and its managementFemale infertility and its management
Female infertility and its management
Sharon Treesa Antony
 
Prolapse of Uterus
Prolapse of UterusProlapse of Uterus
Prolapse of Uterus
Abhishek Joshi
 
Hormonal contraceptives satya ppt
Hormonal contraceptives satya pptHormonal contraceptives satya ppt
Hormonal contraceptives satya ppt
sathyanarayanan varadarajan
 
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSIONAbnormal Uterine BleedingD.G.F. CME CASE STUDY DISCUSSIONAbnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
Lifecare Centre
 
Gestational trophoblastic neoplasia
Gestational trophoblastic neoplasiaGestational trophoblastic neoplasia
Gestational trophoblastic neoplasia
Niranjan Chavan
 
Hormone replacement therapy in Post menopausal women
Hormone replacement therapy in Post menopausal womenHormone replacement therapy in Post menopausal women
Hormone replacement therapy in Post menopausal women
POOJA KUMAR
 
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING  BY DR SHASHWAT JANIMEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING  BY DR SHASHWAT JANI
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Management of Female infertility
Management of  Female infertilityManagement of  Female infertility
Management of Female infertility
Aboubakr Elnashar
 
D&E procedure
D&E procedure D&E procedure
D&E procedure
farranajwa
 
Cervical erison
Cervical erisonCervical erison
Cervical erison
Godwin Pangler
 
Adenomyosis
AdenomyosisAdenomyosis
Adenomyosis
Silah Aysha
 
Abnormal uterine bleeding
Abnormal uterine bleedingAbnormal uterine bleeding
Abnormal uterine bleeding
Ayman Shehata
 
gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)student
 

What's hot (20)

Dysmenorrhea
DysmenorrheaDysmenorrhea
Dysmenorrhea
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
 
Contraception
ContraceptionContraception
Contraception
 
Dilatation and curettage
Dilatation and curettageDilatation and curettage
Dilatation and curettage
 
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE,  Mob: 7289915...
OPERATIONS FOR NULLIPAROUS PROLAPSE AND VAGINAL VAULT PROLAPSE, Mob: 7289915...
 
Abruptio placentae
Abruptio placentae Abruptio placentae
Abruptio placentae
 
Female infertility and its management
Female infertility and its managementFemale infertility and its management
Female infertility and its management
 
Prolapse of Uterus
Prolapse of UterusProlapse of Uterus
Prolapse of Uterus
 
Hormonal contraceptives satya ppt
Hormonal contraceptives satya pptHormonal contraceptives satya ppt
Hormonal contraceptives satya ppt
 
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSIONAbnormal Uterine BleedingD.G.F. CME CASE STUDY DISCUSSIONAbnormal Uterine Bleeding
D.G.F. CME CASE STUDY DISCUSSION Abnormal Uterine Bleeding
 
D&C
D&CD&C
D&C
 
Gestational trophoblastic neoplasia
Gestational trophoblastic neoplasiaGestational trophoblastic neoplasia
Gestational trophoblastic neoplasia
 
Hormone replacement therapy in Post menopausal women
Hormone replacement therapy in Post menopausal womenHormone replacement therapy in Post menopausal women
Hormone replacement therapy in Post menopausal women
 
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING  BY DR SHASHWAT JANIMEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING  BY DR SHASHWAT JANI
MEDICAL MANAGEMENT OF ABNORMAL UTERINE BLEEDING BY DR SHASHWAT JANI
 
Management of Female infertility
Management of  Female infertilityManagement of  Female infertility
Management of Female infertility
 
D&E procedure
D&E procedure D&E procedure
D&E procedure
 
Cervical erison
Cervical erisonCervical erison
Cervical erison
 
Adenomyosis
AdenomyosisAdenomyosis
Adenomyosis
 
Abnormal uterine bleeding
Abnormal uterine bleedingAbnormal uterine bleeding
Abnormal uterine bleeding
 
gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)
 

Similar to COMBINED ORAL CONTRACEPTIVE PILLS AND NEWER ADVANCES IN CONTRACEPTION BY DR SHASHWAT JANI.

HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANIHORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
Hormonal contraceptives
Hormonal contraceptivesHormonal contraceptives
Hormonal contraceptives
Indraneel Jadhav
 
Hormonal contraception
Hormonal contraception Hormonal contraception
Hormonal contraception
Bibhu Sahu
 
Oral hormonal contraceptive
Oral hormonal contraceptiveOral hormonal contraceptive
Oral hormonal contraceptive
magdy abdel
 
Drm science lecture 2 CONTRACEPTIVES AND IUDs
Drm science lecture 2 CONTRACEPTIVES AND IUDsDrm science lecture 2 CONTRACEPTIVES AND IUDs
Drm science lecture 2 CONTRACEPTIVES AND IUDs
Raghu Prasada
 
Combined Contraceptives, Past, Present and Future
Combined Contraceptives, Past, Present and FutureCombined Contraceptives, Past, Present and Future
Combined Contraceptives, Past, Present and Future
Mamdouh Sabry
 
Oral Contraceptives, Up to date Overview
Oral Contraceptives, Up to date Overview Oral Contraceptives, Up to date Overview
Oral Contraceptives, Up to date Overview Mamdouh Sabry
 
Contraception.
Contraception.Contraception.
Contraception.
magdy abdel
 
hormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdfhormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdf
AderawAlemie
 
HORMONAL CONTRACEPTIVES
HORMONAL CONTRACEPTIVESHORMONAL CONTRACEPTIVES
HORMONAL CONTRACEPTIVES
sharonsheregar
 
Mdsepfullpage
MdsepfullpageMdsepfullpage
Mdsepfullpage
Mini Pg
 
Nulife module 7 controversies and conclusions edited
Nulife module 7 controversies and conclusions editedNulife module 7 controversies and conclusions edited
Nulife module 7 controversies and conclusions edited
Maninder Ahuja
 
Methods of contraception
Methods of contraceptionMethods of contraception
Methods of contraception
Walaa Mahmoud
 
Abnormal Uterine Bleeding.pptx
Abnormal Uterine Bleeding.pptxAbnormal Uterine Bleeding.pptx
Abnormal Uterine Bleeding.pptx
CHADUVULA SURESHBABU
 
Endometrios-"an overview"
Endometrios-"an overview"Endometrios-"an overview"
Endometrios-"an overview"
suryanarayan sethi
 
Oral and injectable contraceptive steroids
Oral and injectable contraceptive steroids Oral and injectable contraceptive steroids
Oral and injectable contraceptive steroids
muthulakshmi623285
 
Contraception & Oral Contraceptives
Contraception & Oral ContraceptivesContraception & Oral Contraceptives
Contraception & Oral Contraceptives
Pervej Alom
 
ocp.ppt
ocp.pptocp.ppt
ocp.ppt
mohamed104057
 
Class oral contraceptives
Class oral contraceptivesClass oral contraceptives
Class oral contraceptives
Raghu Prasada
 

Similar to COMBINED ORAL CONTRACEPTIVE PILLS AND NEWER ADVANCES IN CONTRACEPTION BY DR SHASHWAT JANI. (20)

HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANIHORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
HORMONAL CONTRACEPTION & NEWER CONTRACEPTIVES BY DR SHASHWAT JANI
 
Hormonal contraceptives
Hormonal contraceptivesHormonal contraceptives
Hormonal contraceptives
 
Hormonal contraception
Hormonal contraception Hormonal contraception
Hormonal contraception
 
Oral hormonal contraceptive
Oral hormonal contraceptiveOral hormonal contraceptive
Oral hormonal contraceptive
 
Drm science lecture 2 CONTRACEPTIVES AND IUDs
Drm science lecture 2 CONTRACEPTIVES AND IUDsDrm science lecture 2 CONTRACEPTIVES AND IUDs
Drm science lecture 2 CONTRACEPTIVES AND IUDs
 
Combined Contraceptives, Past, Present and Future
Combined Contraceptives, Past, Present and FutureCombined Contraceptives, Past, Present and Future
Combined Contraceptives, Past, Present and Future
 
Oral Contraceptives, Up to date Overview
Oral Contraceptives, Up to date Overview Oral Contraceptives, Up to date Overview
Oral Contraceptives, Up to date Overview
 
Contraception.
Contraception.Contraception.
Contraception.
 
Ormeloxifene copy
Ormeloxifene   copyOrmeloxifene   copy
Ormeloxifene copy
 
hormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdfhormonalcontraception-210101111102 (1).pdf
hormonalcontraception-210101111102 (1).pdf
 
HORMONAL CONTRACEPTIVES
HORMONAL CONTRACEPTIVESHORMONAL CONTRACEPTIVES
HORMONAL CONTRACEPTIVES
 
Mdsepfullpage
MdsepfullpageMdsepfullpage
Mdsepfullpage
 
Nulife module 7 controversies and conclusions edited
Nulife module 7 controversies and conclusions editedNulife module 7 controversies and conclusions edited
Nulife module 7 controversies and conclusions edited
 
Methods of contraception
Methods of contraceptionMethods of contraception
Methods of contraception
 
Abnormal Uterine Bleeding.pptx
Abnormal Uterine Bleeding.pptxAbnormal Uterine Bleeding.pptx
Abnormal Uterine Bleeding.pptx
 
Endometrios-"an overview"
Endometrios-"an overview"Endometrios-"an overview"
Endometrios-"an overview"
 
Oral and injectable contraceptive steroids
Oral and injectable contraceptive steroids Oral and injectable contraceptive steroids
Oral and injectable contraceptive steroids
 
Contraception & Oral Contraceptives
Contraception & Oral ContraceptivesContraception & Oral Contraceptives
Contraception & Oral Contraceptives
 
ocp.ppt
ocp.pptocp.ppt
ocp.ppt
 
Class oral contraceptives
Class oral contraceptivesClass oral contraceptives
Class oral contraceptives
 

More from DR SHASHWAT JANI

STANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptx
STANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptxSTANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptx
STANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptx
DR SHASHWAT JANI
 
EARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANI
EARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANIEARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANI
EARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANITHYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
IMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANI
IMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANIIMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANI
IMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
DENGUE IN PREGNANCY BY DR SHASHWAT JANI
DENGUE IN PREGNANCY BY DR SHASHWAT JANIDENGUE IN PREGNANCY BY DR SHASHWAT JANI
DENGUE IN PREGNANCY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANIDEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
VASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANI
VASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANIVASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANI
VASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
TRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANI
TRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANITRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANI
TRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANIPREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
ECTOPIC PREGNANCY - FOGSI GUIDELINES BY DR SHASHWAT JANI
ECTOPIC PREGNANCY -  FOGSI GUIDELINES BY DR SHASHWAT JANIECTOPIC PREGNANCY -  FOGSI GUIDELINES BY DR SHASHWAT JANI
ECTOPIC PREGNANCY - FOGSI GUIDELINES BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANI
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANIOVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANI
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
OBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANI
OBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANIOBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANI
OBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
NONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANI
NONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANINONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANI
NONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...
DR SHASHWAT JANI
 
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANIMANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANIMANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
MANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANI
MANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANIMANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANI
MANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
GENITAL TB - HOW TO DIAGNOSE & WHEN TO TREAT BY DR SHASHWAT JANI
GENITAL TB - HOW TO DIAGNOSE  & WHEN TO TREAT  BY DR SHASHWAT JANIGENITAL TB - HOW TO DIAGNOSE  & WHEN TO TREAT  BY DR SHASHWAT JANI
GENITAL TB - HOW TO DIAGNOSE & WHEN TO TREAT BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
EXAMINATION OF MALE IN INFERTILITY - WHAT NOT TO MISS BY DR SHASHWAT JANI
EXAMINATION OF MALE IN INFERTILITY  - WHAT NOT TO MISS BY DR SHASHWAT JANIEXAMINATION OF MALE IN INFERTILITY  - WHAT NOT TO MISS BY DR SHASHWAT JANI
EXAMINATION OF MALE IN INFERTILITY - WHAT NOT TO MISS BY DR SHASHWAT JANI
DR SHASHWAT JANI
 
FEVER IN PREGNANCY BY DR SHASHWAT JANI
FEVER IN PREGNANCY BY DR SHASHWAT JANIFEVER IN PREGNANCY BY DR SHASHWAT JANI
FEVER IN PREGNANCY BY DR SHASHWAT JANI
DR SHASHWAT JANI
 

More from DR SHASHWAT JANI (20)

STANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptx
STANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptxSTANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptx
STANDARD TECHNIQUES OF BREAST FEEDING BY DR SHASHWAT JANI.pptx
 
EARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANI
EARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANIEARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANI
EARLY PREGNANCY CHALLENGES IN ART BY DR SHASHWAT JANI
 
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANITHYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
THYROID DISEASES IN PREGNANCY BY DR SHASHWAT JANI
 
IMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANI
IMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANIIMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANI
IMPACT OF DEEP ENDOMETRIOSIS ON PREGNANCY & DELIVERY BY DR SHASHWAT JANI
 
DENGUE IN PREGNANCY BY DR SHASHWAT JANI
DENGUE IN PREGNANCY BY DR SHASHWAT JANIDENGUE IN PREGNANCY BY DR SHASHWAT JANI
DENGUE IN PREGNANCY BY DR SHASHWAT JANI
 
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANIDEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
DEBATE - SHORT CERVIX - OS TIGHTNING BY DR SHASHWAT JANI
 
VASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANI
VASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANIVASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANI
VASOMOTOR PROBLEMS IN MENOPAUSE BY DR SHASHWAT JANI
 
TRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANI
TRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANITRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANI
TRANSFER OF A CRITICALLY ILL MOTHER BY DR SHASHWAT JANI
 
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANIPREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
PREVENTION OF PRETERM LABOUR - EVIDENCES FOR PROGESTERONE BY DR SHASHWAT JANI
 
ECTOPIC PREGNANCY - FOGSI GUIDELINES BY DR SHASHWAT JANI
ECTOPIC PREGNANCY -  FOGSI GUIDELINES BY DR SHASHWAT JANIECTOPIC PREGNANCY -  FOGSI GUIDELINES BY DR SHASHWAT JANI
ECTOPIC PREGNANCY - FOGSI GUIDELINES BY DR SHASHWAT JANI
 
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANI
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANIOVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANI
OVARIAN REJUVENATION - ROLE OF PLATELET RICH PLASMA THERAPY BY DR SHASHWAT JANI
 
OBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANI
OBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANIOBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANI
OBSTETRIC PRACTICES IN PRESENT SCENARIO BY DR SHASHWAT JANI
 
NONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANI
NONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANINONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANI
NONHORMONAL DRUGS FOR MALE INFERTILITY BY DR SHASHWAT JANI
 
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...
F.I.G.O. GUIDELINES & MEDICAL MANAGEMENT OF A.U.B. ( FOCUS ON PROGESTERONE ) ...
 
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANIMANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
MANAGEMENT OF PREECLAMPSIA BY DR SHASHWAT JANI
 
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANIMANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
MANAGEMENT OF GESTATIONAL DIABETES MELLITUS BY DR SHASHWAT JANI
 
MANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANI
MANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANIMANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANI
MANAGEMENT OF COMPLICATIONS OF HYSTEROSCOPY BY DR SHASHWAT JANI
 
GENITAL TB - HOW TO DIAGNOSE & WHEN TO TREAT BY DR SHASHWAT JANI
GENITAL TB - HOW TO DIAGNOSE  & WHEN TO TREAT  BY DR SHASHWAT JANIGENITAL TB - HOW TO DIAGNOSE  & WHEN TO TREAT  BY DR SHASHWAT JANI
GENITAL TB - HOW TO DIAGNOSE & WHEN TO TREAT BY DR SHASHWAT JANI
 
EXAMINATION OF MALE IN INFERTILITY - WHAT NOT TO MISS BY DR SHASHWAT JANI
EXAMINATION OF MALE IN INFERTILITY  - WHAT NOT TO MISS BY DR SHASHWAT JANIEXAMINATION OF MALE IN INFERTILITY  - WHAT NOT TO MISS BY DR SHASHWAT JANI
EXAMINATION OF MALE IN INFERTILITY - WHAT NOT TO MISS BY DR SHASHWAT JANI
 
FEVER IN PREGNANCY BY DR SHASHWAT JANI
FEVER IN PREGNANCY BY DR SHASHWAT JANIFEVER IN PREGNANCY BY DR SHASHWAT JANI
FEVER IN PREGNANCY BY DR SHASHWAT JANI
 

Recently uploaded

24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 

Recently uploaded (20)

24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 

COMBINED ORAL CONTRACEPTIVE PILLS AND NEWER ADVANCES IN CONTRACEPTION BY DR SHASHWAT JANI.

  • 1. Combined Oral Contraceptives Dr Shashwat K. Jani. M.S. ( Gynec ) Diploma in Endoscopy. Assistant Professor, Smt. N.H.L. Medical College. Sheth V. S. General Hospital, Ahmedabad. ( M ) : 99099 44160. E- mail : drshashwatjani@gmail.com
  • 2. Introduction  World’s population expected to reach 9 billion by 2050.  India accounts for 18% of World’s population… !!!  Annually, 529,000 maternal deaths & 50 million morbidity.  In India, contraceptive prevalence is 48.3% .  21% of all pregnancies resulting live births are unplanned….!!!  If unmet need for contraception was met, we can avoid 52 million unwanted pregnancies 25-50% of maternal deaths ( Hindin MJ, Lancet. 2007;370:1297-8 ) Dr Shashwat Jani. 9909944160 2
  • 3. Dr Shashwat Jani. 9909944160 3
  • 4. Dr Shashwat Jani. 9909944160 4
  • 5.  1st Clinical trials of COC were described by John Charles Rock & Goodwin Pincus with approval of marketing in USA in 1960. Within 5 years it was used by 30 millions women all over the world. At the moment , COC is used by over 100 million women worldwide. Dr Shashwat Jani. 9909944160 5
  • 6. Combined Oral Contraceptives ( COC )  Commonly known as the “ Pill “ Widely Accepted & Most Effective Reversible method of Fertility Control.  In 1951, India was the 1st country in world to introduce COC in National programme of Family Planning. Dr Shashwat Jani. 9909944160 6
  • 7. COC : Estrogen + Progestogen  Estrogen : 2 types : - Ethinyl Estradiol ( EE ) - Mestranol ( Not used ) Dr Shashwat Jani. 9909944160 7
  • 8. PROGESTOGENS : ( 4 Groups ) 1 ) Norethisterone Group : ( 1st generation Pills ) Moderate Androgenic property …. Norethisterone, Norethisterone Acetate , Ethiynoidal diacetate , Lynestrenol 2 ) Norgestrel : ( 2nd generation pills ) Strong Progestogenic & Androgenic property…. Dr Shashwat Jani. 9909944160 8
  • 9. 3 ) 19 – nor testosterone derivatives : ( 3rd generation pills ) Anti ovulatory function by suppressing Gonadotropin… Desogestrel, Gestodene, Norgestimate. 4 ) Spironolactone analogue : Antiandrogenic & Anti mineralocorticoid … Drosperinone ( DRSP ) Dr Shashwat Jani. 9909944160 9
  • 10. A comparison of various progestins… Progestin Estro-genic Anti-estrogenic Andro-genic Antiandro -genic Antimineralo -corticoid Progesterone - - - + + Older progestins: MPA - - + - - Norethisterone - + + - - Levonorgestrel - + + - - Newer progestins: Desogestrel Cyproterone acetate - - - - - - - + - - Drospirenone - - - + +
  • 11. Types of COC Dr Shashwat Jani. 9909944160 11
  • 12. 1) Monophasic  Contains Estrogen & Progesterone in same amount in Each pill .  Divided in 2 subgroups : - Low dose pills : EE 30 – 35 microgm - Very low dose pills : EE 15 – 25 microgm. Mala - N • dl – NGL 0.15 mg • EE 0.03 mg Mala - D • l – NGL 0.15 mg • EE 0.03 mg Dr Shashwat Jani. 9909944160 12
  • 13. 2 ) Multiphasic  Contains low or variable amounts of E and P in 2 ( biphasic ) or 3 ( triphasic ) phases of cycles.  Biphasic : constant EE – 35 microgm progestogens : low in first 10 days higher in next 11 days . NOT POPULAR – MORE FAILURE RATE .  NOT AVAILABLE IN INDIA … Dr Shashwat Jani. 9909944160 13
  • 14.  Triphasic : Triquilar – - 0.03 EE +0.5mg l-norgestrel (1 - 6) - 0.03 EE +0.75mg l-norgestrel (7-11) - 0.03 EE +0.125mg l-norgestrel (12 - 21) Total monthly intake – 0.68mg EE +1.92mg progesterone • Adv. – high efficacy rates - few side effects - less break through bleeding - does not affect s.cholesterol & LIPIDS • Disadv. – high pregnancy rates if errors in pill intake . Dr Shashwat Jani. 9909944160 14
  • 15. Mechanism of action: 1 ) Inhibition of Ovulation :  both hormones act on Hypothalamo pituitary axis , suppress release of FSH & LH from Ant. Pituitary. E – inhibits FSH. P – inhibits preovulatory LH Surge , less effect on FSH. Dr Shashwat Jani. 9909944160 15
  • 16. 2 ) Endometrial Hyperplasia :  stromal oedema , decidual reaction & regression of glands making endometrium nonreceptive to embryo. 3 ) Cervical mucus : thick , viscid , scanty . impaired sperm transport & penetration. 4 ) May affect tubal motility & alter tubal transport. Dr Shashwat Jani. 9909944160 16
  • 17. Selection of the patient  Detail history ( headache , migraine , etc…)  Thorough general examination ( Breast , blood pressure… )  Pelvic examination to exclude cervical pathology.  Cervical cytology  Rule out any other contraindications. Dr Shashwat Jani. 9909944160 17
  • 18. Checklist for Prescribing COC… Last menstrual period, rule out pregnancy Less than 6 months postpartum & lactating? Age, Cigarette smoking, h/o migraine Known case of diabetes or hypertension History of stroke, MI or thrombosis h/o jaundice/ liver disease h/o breast/ genital tract malignancies h/o drug intake: Antitubercular, antiepileptic Dr Shashwat Jani. 9909944160 18
  • 19. Administration New User : - 1st day of Cycle . - Daily 1 tab. Preferably at night for consecutive 21 days. - Continued for 21 days and then 7 days break ( with iron tablets ) . - Next pack of Pill should be started on 8th day , IRRESPECTIVE OF BLEEDING ( same day of the week , pill finished ). - Simple Regimen of “ 3 WEEKS ON & 1 WEEK OFF “ - No break between packs.  Can start pill up to 5 days of bleeding with extra precaution with condom for next 7 days. Dr Shashwat Jani. 9909944160 19
  • 20. Missed Tablets : 1 missed – Take 2 tablets next day . 2 or 3 missed – Take 2 tablets on two consecutive days and continue the rest of the pack. +Another Contraceptive for 1 week. Dr Shashwat Jani. 9909944160 20
  • 21. • Lactating Women – Progestogen only pills / Combined pills after 6 months • Non Lactating Women – Combined oral pills after 3 to 6 weeks or after menstruation • 1st / 2nd Trimester abortion – during first 7 days. • Amenorrhea : At any time after excluding pregnancy + barrier method for 7 days. Dr Shashwat Jani. 9909944160 21
  • 22. Extended Use of COC… (Seasonale) Available since 2003 150μg of LNG + 30μg of EE Only Active Pills taken continuously for 84 days, then break for 7 days. Fewer periods (4 in a year) Pearl index- 0.78 Breakthrough bleeding/ spotting – First few cycles
  • 23. Follow up …  Examined after 3 months , then after 6 months and then yearly .  Ask for any symptoms…  Examination for breast , pelvis, BP & weight & cervical cytology. Dr Shashwat Jani. 9909944160 23
  • 24. Effectiveness… Failure rate : 0.1% Failure rate are mainly due to missed pills. Dr Shashwat Jani. 9909944160 24
  • 25. How long can be continued …??? In properly selected patient without any risk factor , benefits are more , and so can be continued up to age of 50 with careful monitoring. Offers dual advantage of Contraception and HRT. For spacing of birth : 3 – 5 years. Dr Shashwat Jani. 9909944160 25
  • 26. Advantages… • Prevention of pregnancy India - MMR 1per 57 i.e. 400 in 1,00,000 2/5th of these deaths can be prevented by use of OCs • Cyclical Stabilisation Great social advantage. Withdrawl bleeding is predictable & postponed safely by taking more low dose pills contineously . Dr Shashwat Jani. 9909944160 26
  • 27. • Cure of Menstrual Disorders Dysmenorrhoea & Ovulation pain – By inhibiting ovulation & production of PG . Menorrhagia & Metrorrhagia - Norgestrel High dose oral pills more useful. Lessens PMT. • Protection against Cancer a) Endometrial cancer- Reduction by 50 % effect persists for 15 yrs. b) Ovarian Cancer – Reduction by 40 % effect persists for 10 yrs. c) Choriocarcinoma – Indirectly prevention by preventing pregnancy. Dr Shashwat Jani. 9909944160 27
  • 28. • Protection against benign tumors 1) Fibrocystic and Fibroadenomatous disease 2) Ovarion Functional Cysts 1) Follicular Cyst – 50 % 2) Corpus Luteum Cyst – 80 % 3) Fibroid Uterus - Reduction by 30% Low Dose OC’s reduce fibroid ( WHO 1996) Dr Shashwat Jani. 9909944160 28
  • 29. • Protection against diseases 1) Ectopic Pregnancy 2) PID 3) Anaemia and Malnutrition 4) Endometriosis 5) Acne and Hirsutism 6) DUB 7) Osteoporosis • Simplicity and Attractiveness • No Affection on Future fertility ( 3 months ) Dr Shashwat Jani. 9909944160 29
  • 30. Emergency Contraception… 1) Yuzpe regimen – 0.1mg EE + 1 mg dl-Norgestrel 1st dose Within 72 Hrs of Contact Repeated after 12 Hrs. 2) Ovral 1st dose 2 tablets within 72 hrs. 2nd dose 2 tablets after 12 hrs. 3) Overal – L 1ST dose 4 tablets within 72 hrs. 2nd dose 4 tablets after 12 hrs. Dr Shashwat Jani. 9909944160 30
  • 31. Minor Side Effects… • Nausea, Vomiting and Lack of appetite • Break through bleeding • Menorrhagia and irregular bleeding • Oligomenorrhoea and Amenorrhoea • Breast changes – Heaviness and Tenderness • Vaginal Discharge – Cx -erosion, dysplasia causes leucorrhoea • Headache and Migraine • Chloasma • Wt. Gain • Psychosexual Trouble – Depression, Loss of Libido • Others - Leg Cramps, Dimness of Vision Dr Shashwat Jani. 9909944160 31
  • 32. Major Side Effects… • Cardiovascular Diseases 1) MI – Increased Risk in heavy smokers 2) Ischaemic Stroke - 1.5 times more 3) Haemorrhagic Stroke – double risk 4) Venous Thromboembolism – Risk increases with age, recent surgery and thrombophilia • Hypertension - In women more than 35 Yrs. • Carcinogenecity 1) Breast Cancer 2) Cervical Cancer Dr Shashwat Jani. 9909944160 32
  • 33. Interaction With Drugs… 1) Barbiturates , Sulphonamides, Rifampicin and Anticonvulsant interfere with OC’s and failure rate increases 2) Interaction with antidiabetic drugs 3) Vit. C aggravates the effect of COC. Dr Shashwat Jani. 9909944160 33
  • 34. Absolute Contraindications… (WHO Category IV) • Migraine, with focal Neurological Symptoms • Pregnancy and breast feeding ( 6 Months) • Severe Hypertension • Complicated valvular heart disease • D.M. with vascular complications • Active hepatitis, liver tumors • Major Surgery • Prolonged Immobilization . Dr Shashwat Jani. 9909944160 34
  • 35. Indications of Withdrawal :  Severe migraine Visual or speech disturbances Sudden chest pain Unexplained fainting attack or acute vertigo Severe leg cramps Excessive weight gain Severe depression Prior to surgery ( Atleast 6 weeks ) Patient wants pregnancy …  Dr Shashwat Jani. 9909944160 35
  • 36. NEWER CONTRACEPTIVES Dr Shashwat Jani. 9909944160 36
  • 37. MALE  GOSSYPOL : - A Chinese drug … !!!  - extract from Cotton seed. - Oral 10 – 20 mg daily for 3 months then 20 mg twice weekly. - Inhibit Spermatogenesis by acting on seminiferous tubules. - S/E : fatigue, decrease libido, hypokalamic paralysis. Dr Shashwat Jani. 9909944160 37
  • 38. Polyurethane Male Condom • Stronger and thinner than latex condoms • Better heat transmission • Can safely be used with oil-based lubricants • Can be used by those with latex allergies
  • 39.  GnRH Analogues : - decline in sperm density , sperm motility, decrease in testosterone level. - Marked loss of libido makes it unacceptable . Add back therapy with Testosterone is given. Dr Shashwat Jani. 9909944160 39
  • 40. Male Hormonal Contraception • Recent trials at Andrology Clinic, Concord Hospital • Depo Provera plus testosterone implants 3 monthly. • Very low sperm count (less than 1 million per ml) in all men on trial - 80% had no sperm. • Few side-effects • Similar regime using an oral progestogen and testosterone implants being trialed in UK • Implants and testosterone also being trialled.
  • 41. RISUG : - “Reversible Inhibition of Sperm Under Guidence . “ - Developed by IIT & AIIMS. - clear polymer gel made of Styrene maleic anhydrate ( SMA ) mixed with Dimethyl Sulphoxide ( DMSO ) injected in to Vas deferens  partially blocks Vas , preventing sperm from coming in to ejaculate. - Phase I & Phase II trials cleared. - VASALGEL is similar to it. Dr Shashwat Jani. 9909944160 41
  • 42. Intra Vas Device ( IVD ) – Shug : - 2 devices inserted in to each Vas . - Needs special surgical skill. - wider trials needed. Dr Shashwat Jani. 9909944160 42
  • 43. Voegeli’s Heat Method • A small increase in the temperature of the testes has a large negative impact on the production of sperm (spermatogenesis). • Voegeli’s program for temporary sterilization is as follows: “A man sits in a [shallow or testes-only] bath of 116 degrees Fahrenheit for forty-five minutes daily for three weeks. Six months of sterility results, after which normal fertility returns. For longer sterility, the treatment is repeated. ” • . Dr Shashwat Jani. 9909944160 43
  • 44. Artificial Cryptorchidism/ Suspensories (a) testes in normal position; (b) testes raised to near inguinal canal; testes held in place with (c) briefs with ring of soft rubber or (d) ring alone. Dr Shashwat Jani. 9909944160 44
  • 45. Gendarussa • First nonhormonal male contraceptive pills. • Developed by Indonesia. • Active ingredient in Gendarussa disrupts an enzyme in the sperm head, which weakens the ability of the sperm to penetrate the ovum. • The effect is short term and reversible – having no effect on male hormones. • Still under clinical trials… Dr Shashwat Jani. 9909944160 45
  • 46. Nifedipine – CCB • CCBs also partially block the calcium channels within the cell membranes of sperm. This affects sperm function rather than production. • A man taking nifedipine produces a normal amount of sperm, and the sperm appear functional when viewed through a microscope. But in vitro tests show that these sperm cannot fertilize an egg. Dr Shashwat Jani. 9909944160 46
  • 47. Male Vaccines … • Scientists are trying to isolate, identify, and produce Anti sperm surface antigens which will hinder sperm – egg without side effects. • Will take long time… Dr Shashwat Jani. 9909944160 47
  • 48. Other Ongoing trials… • Use of following as Male Contraceptives… 1 ) Neem extracts. 2 ) retinoic receptor antagonist 3 ) papaiya seed extracts 4 ) olealonic acid Dr Shashwat Jani. 9909944160 48
  • 49. FEMALE Many researches are going on for development of newer Contraceptives for females which are either Non Hormonal OR having low dose of Estrogen and newer Progestogens. Dr Shashwat Jani. 9909944160 49
  • 50. PATH Women’s Condom • Polyurethane condom pouch • Foam dots improve adherence to vaginal walls • Soft outer ring • Dissolving capsule Dr Shashwat Jani. 9909944160 50
  • 51. SILCS Diaphragm • Cervical barrier device • One-size-fits most • Developed with input from women and men in multiple countries • Regulatory application in Europe & US. Dr Shashwat Jani. 9909944160 51
  • 52. Centchroman ( Saheli ) • Ormeloxifene . • research product of CDRI , Lucknow • Non steroidal , potent anti estrogenic , weak estrogenic. • Prevent implantation of fertilized ovum . • Orally 30 mg twice weekly for first 3 months then once a week. • Avoided in PCOD, liver , kidney disease. Dr Shashwat Jani. 9909944160 52
  • 53. Non contraceptive uses … • DUB • Endometrial Hyperplasia • Endometriosis • Breast cancer • HRT Dr Shashwat Jani. 9909944160 53
  • 54. Combined Injectable Contraceptives • CYCLOFEM : - DMPA 25 mg + Ostradiol cypionate 5 mg. • MESIGYNA : - NET- EN 50 mg + Oestradiol valerate 5 mg. • Given within first 5 days of menstruation • Next dose on same date of each month. Dr Shashwat Jani. 9909944160 54
  • 55. New formulation of Depo-Provera: Depo-subQ Provera 104, for delivery with Uniject Depo-subQ Provera 104:  New formulation for subQ injection  30% lower dose (104 mg vs. 150 mg)  Rapid onset of action  Same effectiveness, same length of protection (>3 months)  Approved by USFDA (2005) and UK  Potential for home- and self-injection  Available for roll-out in 2011; Acceptability studies to begin in mid-2010 Uniject:  Single dose, single package  Prefilled, sterile, non-reusable  Short needles for subQ injection (easier use by non-clinical personnel/CHWs)  Compact; easy to use and store Potential “home run”
  • 56. Transdermal delivery system • Nestorone ( newer progestin ) : - Available as Cream & Patch. - Patches used like pills : 3 weeks ON 1 week OFF. Dr Shashwat Jani. 9909944160 56
  • 57. VAGINAL RINGS • LNG ring covered by silastic tube . • Delivers 20 microgm / day • Replaced every 3 months. Dr Shashwat Jani. 9909944160 57
  • 58. Combined Ring – NUVA RING : • Soft, transperent, ethinyl vinyl ring • Releases EE 15 microgm + Etonogestrel daily over a period of 21 days. • Then removed , after 1 week ( bleeding ) new ring inserted. • S/E : headache, leucorrhea, vaginitis Dr Shashwat Jani. 9909944160 58
  • 59. LNG ROD • Implant with total 150 mg of LNG ( 75 mg / rod ) is found effective for 5 years. UNIPLANT • Single rod implant • Nomegestrol 38 mg. • Releases 100 microgm / day. • For 1 year. Dr Shashwat Jani. 9909944160 59
  • 60. Biodegradable • Cipronor ( Single Capsule) – IMPLANTS : - LNG 26 mg - begins to disappear after 12 months. • INJECTABLE : - Microsphere of 0.06 – 0.1 mm diameter with Norethindrone with or without EE. - Given over Gluteal muscle. - Once injected , can’t be removed. Dr Shashwat Jani. 9909944160 60
  • 61. Quinacrine pellet • It acts as Sclerosing agent • Inserted transcervically through hysteroscope in proliferative phase. • Repeated in next cycle. • Long term results are awaited. Dr Shashwat Jani. 9909944160 61
  • 62. Frameless IUD - Gynefix • Made of 6 copper beads ( 330 sqmm of Cu ) on monofilament polypropylene thread. • Thread is knotted at one end , embeded in to fundal myometrium up to 1 cm. • Reduced risk of Expulsion, Dysmenorrhoea, Bleeding , Infection. • Can be used in Nulliparous. • Removed with Hook. Dr Shashwat Jani. 9909944160 62
  • 63. Gynefix Dr Shashwat Jani. 9909944160 63
  • 64. ESSURE • Transcervical sterilisation • 4 cm long , 2 mm diameter microcoil • Spring like device • Inserted in each fallopian tube through hysteroscope. • Tube is blocked permanently when scar tissue grow inside. Dr Shashwat Jani. 9909944160 64
  • 65. Dr Shashwat Jani. 9909944160 65

Editor's Notes

  1. 55